ClinicalTrials.gg
Drug

Lisdexamfetamine clinical trials

Also written Vyvanse, SPD489 and NRP104.

Includes 1 study of Lisdexamfetamine sulfate.

studies test it
97
open now
1
in phase 3
32
first study started
2004

How each study uses lisdexamfetamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the lisdexamfetamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Feb 2007 · VYVANSE · NDA 021977 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lisdexamfetamine Dimesylate
26
Lisdexamfetamine
25
LDX
7
SPD489 (Lisdexamfetamine dimesylate)
6
Lisdexamfetamine Dimesylate (LDX)
4

Brand

Vyvanse
46

Development codes

SPD489
9
NRP104
5

Studies by the year they started

97 studies that test it; most in 2009 (13)

Studies that test lisdexamfetamine, by start year
YearStudies
20042
20051
20063
20073
200811
200913
201011
201112
20129
20137
20144
20156
20174
20184
20193
20221
20231
20241
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
11
Phase 2
18
Phase 3
32
Phase 4
30
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 48 · Other 49

Shire (40) · New River Pharmaceuticals (6) · University of Pennsylvania (5) · New York State Psychiatric Institute (4) · Lindner Center of HOPE (4) · University of Minnesota (3) · Yale University (3) · Duke University (3)

Often tested with

Tested in the same studies.

Methylphenidate (4) · Guanfacine (3) · Adderall (2) · LDX 50 (1) · LDX 70 (1) · Behavioral Intervention (1) · Estradiol (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses lisdexamfetamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 97

See all 97 studies that test lisdexamfetamine →

Given beside what is tested · 2 — lisdexamfetamine is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with lisdexamfetamine

Codes

What other systems call lisdexamfetamine · ClinicalTrials.gg INT006599

  • MeSH (NLM) D000069478Lisdexamfetamine DimesylateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) H645GUL8KJLISDEXAMFETAMINEConfirmed FDA, NLM, Wikidata
  • RxNorm 700810Confirmed FDA, Wikidata
  • Wikidata Q6558704lisdexamfetamineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C75114LisdexamfetamineOne source FDA
  • DrugBank DB01255One source Wikidata

Also registered as lisdexamfetamine dimesylate (UNII SJT761GEGS · RxNorm 673579).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.